Jian-cheng Ding
Xiang'an South Road
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo.
A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo.
Journal: Pharmacological research
Published: July 01, 2025
A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo.
Journal: Journal of medicinal chemistry
Published: May 07, 2024
Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 02, 2024
CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development.
Journal: Nucleic acids research
Published: November 23, 2023
MAVI1, an endoplasmic reticulum-localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion.
Journal: Science advances
Published: September 01, 2023
LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis.
Journal: Cellular and molecular life sciences : CMLS
Published: May 08, 2023
Estrogen-Induced LncRNA, LINC02568, Promotes Estrogen Receptor-Positive Breast Cancer Development and Drug Resistance Through Both In Trans and In Cis Mechanisms.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 14, 2022
CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS.
Journal: The EMBO journal
Published: August 18, 2022
Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis.
Journal: Molecular cancer
Published: October 01, 2021
BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 09, 2020
Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
Journal: Theranostics
Published: February 25, 2020
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo.
Journal: Clinical & translational immunology
Published: January 22, 2020
Last Updated: 09/26/2026